Results 31 to 40 of about 6,495 (271)

How Effective Is Vitamin C for Gingival Depigmentation? A Scoping Review. [PDF]

open access: yesClin Exp Dent Res
ABSTRACT Objectives Excessive gingival pigmentation can be treated by surgically removing the pigmented gingival tissue with a scalpel, bur, LASER, electrocautery, cryotherapy, chemical peeling, or masking with free gingival grafts. Recently, vitamin C (ascorbic acid), in gel, powder, or liquid has been used alone or as an adjunct to micro‐needling or ...
Mehrotra S   +4 more
europepmc   +2 more sources

Effect of microneedling by dermaroller on acne scars: an observational study at tertiary care hospital [PDF]

open access: yes, 2023
Background: Post acne facial scar is very distressing phenomenon. There are many treatment options like laser resurfacing, dermabrasion, microdermabrasion and non-ablative laser resurfacing but it may cause adverse effects and interference with the daily
A. Mistry, Ankita   +3 more
core   +2 more sources

Research Progress on Platelet‐Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia [PDF]

open access: yesJ Cosmet Dermatol
ABSTRACT Background Androgenetic alopecia (AGA) is the most common cause of progressive hair loss, significantly affecting quality of life. Current therapies, such as minoxidil, finasteride, and hair transplantation, show variable efficacy and may be associated with adverse effects.
Zhong Z, Luo L, Zhao L, Yue X, Lu Y.
europepmc   +2 more sources

Skin Cell Proliferation Stimulated by Microneedles [PDF]

open access: yes, 2012
A classical wound may be defined as a disruption of tissue integrity. Wounds, caused by trauma from accidents or surgery, that close via secondary intention rely on the biological phases of healing, i.e., hemostasis, inflammation, proliferation, and ...
Kloth, Luther C., Liebl, Horst
core   +2 more sources

Does microneedling with 5% minoxidil offer added advantage for treatment of androgenetic alopecia in comparison to use of topical 5% minoxidil alone? [PDF]

open access: yes, 2020
Background: Androgenetic alopecia is the most common cause of chronic hair loss. The FDA approved treatment for male androgenetic alopecia are Finasteride and Minoxidil. But many patients do not respond to these medications.
Herakal, Kallappa C., Malhotra, Karan
core   +2 more sources

Dermal regeneration with MilliGraft® kit of nanofat: the micrograft of adipose tissue. A clinical assessment study [PDF]

open access: yes, 2019
The simple filtration by means of the MilliGraft® Kit of a disaggregated lipoaspirate allows to extract the class of cells defined as progentors with characteristics of adult stem cells present in the nanofat exclusively on the basis of their dimensions.
Svolacchia, Fabiano, Svolacchia, Lorenzo
core   +1 more source

Androgenic alopecia; the risk–benefit ratio of Finasteride [PDF]

open access: yes, 2018
Finasteride is currently approved and largely used as a therapeutic option for androgenetic alopecia. Apparently a safe drug and effective at the onset of its application, several concerns have since appeared over the years regarding the frequency and ...
Banu, Petrișor   +6 more
core   +3 more sources

Current evidence and applications of photodynamic therapy in dermatology [PDF]

open access: yes, 2014
In photodynamic therapy (PDT) a photosensitizer – a molecule that is activated by light – is administered and exposed to a light source. This leads both to destruction of cells targeted by the particular type of photosensitizer, and immunomodulation ...
Lin, Jennifer Y, Wan, Marilyn T
core   +2 more sources

Microneedle patch tattoos

open access: yesiScience, 2022
Medical tattoos provide medical information, guide radiotherapy, and improve cosmetic outcomes of medical interventions. These tattoos are administered by repeated needle injection that causes pain, bleeding, and risk of infection, which limit more widespread use.
Song Li   +3 more
openaire   +2 more sources

Evaluation of laser bacterial anti-fouling of transparent nanocrystalline yttria-stabilized-zirconia cranial implant. [PDF]

open access: yes, 2016
Background and objectiveThe development and feasibility of a novel nanocrystalline yttria-stabilized-zirconia (nc-YSZ) cranial implant has been recently established.
Aguilar, Guillermo   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy